Company profile
Santhera Pharmaceuticals Ltd.
We are a global specialty pharmaceutical company based in Switzerland committed to development and commercialization of innovative medicines to meet the needs of patients living with rare diseases.
Source: startup.ch
Highlights
Innosuisse Certificate
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
